| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |